Thursday, September 21, 2017
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
(March 20, 2017)

WALTHAM, Mass., March 20, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR-B). The dividend is payable on April 17, 2017 to holders of record of Series B stock at the close of business on April 3, 2017.

Such payment will cover the amount of all dividends accrued from January 1, 2017 through March 31, 2017.

About Alere
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters. Alere delivers on this vision by providing reliable and actionable information through rapid diagnostic tests, enhancing clinical and economic health outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit

To view the original version on PR Newswire, visit:

SOURCE Alere Inc.

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords: Inc., Medicine, Disease, Surgery, Business,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines